6th Jun 2008 13:10
News Release
6 June 2008
PUBLICATION OF COMBINED CIRCULAR AND PROSPECTUS
Further to the announcement yesterday by Vernalis plc (LSE: VER) of the sale of Apokyn® and its US Commercial Operations to Ipsen S.A. (Euronext: IPN) and the subscription by Ipsen for Vernalis ordinary shares, Vernalis today announces that a combined circular and prospectus in relation to the sale and subscription (the Circular) has been published and will be posted to shareholders today.
The Circular is now available for inspection at the UK Listing Authority's Document Viewing Facility, situated at The Financial Services Authority, 25 The North Colonnade, Canary Wharf, London E14 5HS and at the offices of Allen & Overy LLP, One Bishops Square, London E1 6AD during normal business hours on any weekdays (Saturdays, Sundays and public holidays excepted).
The Circular will also shortly be available on the Company's website at www.vernalis.com.
-- ends --
Enquiries:
|
Vernalis plc |
+44 (0) 118 977 3133 |
|
Tony Weir, Chief Financial Officer |
|
|
|
|
|
Brunswick Group |
+44 (0) 20 7404 5959 |
|
Jon Coles |
|
|
Justine McIlroy |
|
Related Shares:
Vernalis PLC